Mr Raymond Wallace Iii, LPN | |
23861 South Robin Rd, Mandeville, LA 70448 | |
(985) 624-4100 | |
Not Available |
Full Name | Mr Raymond Wallace Iii |
---|---|
Gender | Male |
Speciality | Licensed Vocational Nurse |
Location | 23861 South Robin Rd, Mandeville, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568821874 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 20101002 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Raymond Wallace Iii, LPN Po Box 37, Mandeville, LA 70470-0037 Ph: () - | Mr Raymond Wallace Iii, LPN 23861 South Robin Rd, Mandeville, LA 70448 Ph: (985) 624-4100 |
News Archive
PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.
Combining knowledge of chemistry, physics, biology, and engineering, scientists from McGill University develop a biomaterial tough enough to repair the heart, muscles, and vocal cords, representing a major advance in regenerative medicine.
Research from Saint Louis University finds that among patients at risk for opioid misuse, the odds of receiving a schedule II opioid for non-cancer pain were similar to those not at risk, despite new prescribing guidelines from the Centers for Disease Control (CDC).
The 2011 revision of the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) was published in the November 2011 issue of the Journal of Spinal Cord Medicine.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion's Stalevo® tablets.
› Verified 2 days ago